Boston Professional Events List


Drug discovery and Therapy world congress


Date
Jul 10, 2017 - 08:55 AM - Jul 13, 03:10 PM
Organizer
Eureka Conferences, Inc
Venue
The Westin Copley Place
Location
10, Huntington Ave

Boston,
MA,
USA,
ZIP: 02116
Phone:

Benefits of Attending

Exchange ideas and network with leading pharmaceutical scientists and clinicians.

Brings together top international scientists and clinicians presenting cutting-edge discoveries, research and new therapeutic drugs.

This conference aims to span the interdisciplinary fields of pre-clinical and clinical drug discovery and drug therapy and to highlight the burgeoning fields of Translational Medicine - and the major advances from "bench to bedside" research and practice.

Participants can gain direct access to a core audience of professionals and decision makers and can increase visibility through branding and networking at the conference.

Obtain a global roundup of Pharmaceutical research capabilities and opportunities.

Who Should Attend

 

The conference will appeal to a targeted group of scientists and senior international decision makers. Delegates will have a valuable, informative and positive experience.

Pharmaceutical scientists

Clinicians/Doctors

CEOs, CROs, senior instrumental professionals directors and research associates from the pharmaceutical industry and academia



Agenda


    INAUGURAL PROGRAM
                                                              Location: Ball Room ‘B’ - Level 3
8:55 - 9:00 am Guests to be Seated  
 
9:00 - 9:15 am Welcome Remarks by Chairmen Organizing Committee Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-ur-Rahman, FRS
Chairman:
Co-Chairman:
JOINT PLENARY SESSION
Location: Ball Room ‘B’ - Level 3
Time Speakers
 
                                                 Titles
 
9:15 - 10:00 am Stephen J. Elledge
PL
Aneuploidy Promotes Cell Proliferation and Inhibits Immune Surveillance 
10:00 - 10:45 am
 
Kenneth C. Anderson
PL
Title Awaited  
COFFEE & SOCIAL MIXER: 10:45 – 11:15 AM
Locations Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
Lecture Hall 203
Level 2
Tracks Inflammation & Immunology Pharmaceutical Research & Development Plant & Environment
Anti-Infectives High-throughput Screening & Laboratory Automation
Translational Medicine Drug Delivery & Targeting Regenerative Medicine
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
11:15 - 11:45 am 11:15 - 11:45 am 11:15 - 11:45 am
IL
Stephen T. Sonis
Title Awaited
IL
Rathnam Chaguturu
Drug Discovery Efforts Mirror the Proverbial Hyper Cycle: What’s Next?
IL
Hong-Qing Ling
Molecular Regulation Mechanisms of Iron Uptake and Homeostasis in Plants
11:45 - 12:05 pm 11:45 - 12:05 pm 11:45 - 12:05 pm
SL 
Mario Milani
The Difficult Path Toward the Knowledge: An Ongoing Story on New Dengue Virus Inhibitors
SL
Ravindra Peravali
Drug Discovery and Testing Using High-throughput Morphological and Behavioral Screening of Zebrafish Larvae
SL
Robert Bensen
Improving Drought Tolerance in Crop Plants: An Industry Perspective
12:05 - 12:25 pm 12:05 - 12:25 pm 12:05 - 12:35 pm
SL
Concepcion Gonzalez-Bello   
Freezing the Essential Motion of Key Bacterial Enzymes – A Strategy for Antibiotic Drug Discovery
SL
Christian Zoschke
The Barrier Function of Organotypic Non-melanoma Skin Cancer Models
IL
Zoran Ivanovic
Anaerobis and Stemness: An Evolutionary Paradigm for Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells
12:25 - 12:45 pm 12:25 - 12:45 pm 12:35 - 12:55 pm
SL
F. Cordell
Title Awaited
 
SL
Muhammad Qadir
Novel Radiolabeled Polydenatate Ligands as Potential Diagnostic Probes
SL
Florelle Gindraux
Human Amniotic Membrane and Regenerative Medicine
12:45 - 1:05 pm 12:45 - 1:05 pm 12:55 - 1:15 pm
SL
Roman Maciej Kalina
Placebo Effect as Starting Point of the Use of InnovativeAgonology in the Therapy and Treatment
SL
Ajid Sharma
Drug Entrapment in Dendrimers
SL
Nassim H. Abi Chahine
The Regentime Procedure, A Safe Way for Regeneration
 
                                                                                                                                    LUNCH BREAK: 1:00 – 2:30 PM
Locations Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
Lecture Hall 203
Level 2
Tracks Proteomics & Bioinformatics Genomics Regenerative Medicine
Recent Advances in Patient Treatment and Care  
Medical Imaging Academic CRO/Industrial Collaborations in Drug Discovery
Drug Discovery in Pre-Clinical Research Nutraceutical Drug Discovery & Therapy
 
Chairman:  
Co-Chairman:
Chairman:
Co-Chairman: 
Chairman:
Co-Chairman:
2:30 - 3:00 pm 2:30 - 3:00 pm 2:30 - 3:05 pm
IL
Fazlul Huq
Tumour Active Phytochemicals Found to Enhance Platinum Action in Ovarian Tumour Models
 
IL
Henry M. Sobell   
The Centers of Premeltons Signal the Beginning and Ends of Genes
KNL
Ali Khademhosseini
Nano-and Microfabricated Hydrogels for Regenerative Engineering
3:00 - 3:20 pm 3:00 - 3:20 pm 3:05 - 3:25 pm
SL
Nitin Mathendra Chauhan
Title Awaited
 
SL
Doris Vandeputte
The Gut Microbiome in Health and Disease, The Importance of Quantitative Microbiome Profiling
SL
Leonora Buzanska
Physiological Normoxia as a Strategy to Obtain Therapeutically Competent Cells for the Treatment of CNS Disorders
3:20 - 3:40 pm 3:20 - 3:40 pm 3:25 - 3:45 pm
SL
Yi Zhang
In Vivo Imaging of Neuxial Inflammation in Sciatica Pain with PET/MRI
SL
Van Steen Kristel
Systems Genetics for Precision Medicine
SL
Bruno Delorme
The Concept of Mesenchymal Stem Cells: From Their Discovery to Innovative MSC-derived Therapies
 
3:40 - 4:15 pm 3:40 - 4:00 pm 3:45 - 4:05 pm
KNL
M. Iqbal Choudhary
New Pharmacophores from Medicinal Plants
 
SL
Fentaw Abegaz
Epistasis Detection for Human Complex Diseases in Structured Populations
SL
Swami Shraddhamayananda
Perfect Regeneration in Burn Injury Following Alternative Medicine Therapy
4:15 - 4:35 pm 4:00 - 4:20 pm 4:05 - 4:25 pm
SL
Tatsuya Takimoto
Study on the Correlation Between Structures of BithiazoleDerivatives and Plasmid DNA Cleavage Activity by Using Simulation and Experiment
SL
Ali Noroozi Mobarake
Quality of Health Tourism in Patients Admitted to Shiraz Level I Trauma Center A Field Study of Iran
SL
Hae Lin Jang
An Explanation of the Ratio Between Hydroxyapatite andWhitlockite in Bone: Interplay of the Two Major Nanocrystals for Bone Formation
4:35 - 4:55 pm 4:20 - 4:40 pm 4:25 - 4:45 pm
SL
Maayan Gal
Computational and Biophysical Tools Towards PPIs Drug Discovery
SL
William J. Rowe
Neil Armstrong Syndrome and Thermoregulation
SL
Metiner Tosun
Functional Genomics Analysis of Hepatocellular Tumor-Initiating Cells
4:55 - 5:15 pm 4:40 - 5:00 pm 4:45 - 5:05 pm
  SL
O.J. Sharaibi
Effects of Nymphaea Lotus on Metoclopramide-induced Hyperprolactinemic Female Rats
SL
Jung Park
Electric Field-guided Stem Cell Differentiation on TiO2Nanotubular Surfaces
  5:00 - 5:20 pm  
 
 
SL
Chandrakanth Emani
Basil, Ginger, Neem and Tobacco Extracts as Alternative and Integrative Treatment Options for Cancer
 
COFFEE BREAK: 5:00  - 5:30 PM
                     
                     


 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  DAY 2: Tuesday, July 11, 2017
  Chairman: 
Co-Chairman:
JOINT PLENARY SESSION
Location: Ball Room ‘B’ - Level 3
  Time                  Speakers                                                            Titles
  9:00 - 9:45 am PL
Shuji Ogino
Emerging Pharmaco-MPE (Molecular Pathological Epidemology) and Immuno-MPE For Precision Medicine   
  9:45 - 10:30 am PL
Rudolf Jaenisch
Epigenetics, Stem Cells and Disease Research   
COFFEE & SOCIAL MIXER: 10:30 - 11:15 AM
  Locations Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
Lecture Hall 203
Level 2
  Tracks Innovative Drug Discovery and Nanotechnology Protein & Peptide Sciences Pharmaceutical Biotechnology
 
      Food Biotechnology
  Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
  11:15 - 11:50 am 11:15 - 11:45 am 11:15 - 11:50 am
  KNL
Thomas J. Webster     
The Age of “Nano-biotics”: Self-assembled Materials as Novel Antibacterial Agents Against Drug-resistance Bacteria
IL
 E. Brad Thompson    
Protein Intrinsic Disorder in Drug Design and Use
KNL
M.I. Choudhary
Biotransformation of Existing Drugs – Way Forward for Cost Effective Lead Discovery
 
  11:50 - 12:20 pm 11:45 - 12:05 pm 11:50 - 12:20 pm
  IL
Antonino Mazzaglia     
Nanomaterials Based on Cyclodextrin: Design, Advances in (Photo) Therapeutics Delivery and Bio-performances
SL
Collin M. Stultz     
Dynamics of Alpha-synuclein Aggregation
IL
Michael Hust  
Development of Recombinant Antibodies Against Pathogens and Toxins for Diagnostics and Therapy
  12:20 - 12:40 pm 12:05 - 12:25 pm 12:20 - 12:40 pm
  SL
Keiichi Motoyama    
Mitophagy-mediated Novel Cell Death Induced by Folate-appended Methyl-β-cyclodextrin
SL 
William A. Elam 
A Protein Stabiling Osmolyte Restores Mutant Glucocorticoid Receptor Binding
SL
Luciano Puzer  
Generation of A Recombinant SCFV-FC Against Human Tissue Kallikrein 7
  12:40 - 1:00 pm 12:25 - 12:45 pm 12:40 - 1:00 pm
  SL
Reggie Dela Cruz
Title Awaited
SL
Lidija Covic
Pepducins as Allosteric Agents and Therapeutics to Prevent Coronary Artery Thrombosis and NASH
SL
Sujata Mohanty
Effect of Environment and Growth Phase on Curcumin Production and Differential Gene Expression in Cu
    12:45 - 1:05 pm  
    SL
Lei Li  
Discovery and Pharmacological Evaluation of NovelCaeridins with Smooth Muscle Activities, Isolated from the Skin Secretion of the Australian White’s Tree Frog, Litoria
 
  LUNCH BREAK: 1:00 - 2:30 PM
  Locations Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
Lecture Hall 203
Level 2
  Tracks Innovative Drug Discovery and Nanotechnology Drug Discovery in Preclinical Research Pharmaceutical Biotechnology
 
  Chemistry / Combinatorial Chemistry Diabetes and Obesity Drug Discovery and Therapy  
  Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
  2:30 - 2:50 pm 2:30 - 3:00 pm 2:30 - 2:50 pm
  SL
Geraldine Gouhier    
Cyclodextrins: An Appropriate Scaffold for New MRITheranostic Probes
IL
I.Nagy    
Title Awaited
SL
Johan Nilvebrant   
Antibody Libraries Based on An Autonomous Human Variable Domain
  2:50 - 3:10 pm 3:00 - 3:20 pm 2:50 - 3:10 pm
  SL
Lajos Szente   
Therapeutic and Diagnostic Utility of CyclodextrinDerivatives
SL
Sini Junttila      
Bioinformatic Next Generation Sequencing Data Analysis Workflow for Preclinical Studies
SL
Vacant Slot
3:10 - 3:30 pm 3:20 - 3:40 pm 3:10 - 3:30 pm
SL
Valentina Rapozzi   
Innovative Drugs in Photodynamic Therapy
SL
Paul B. Watkins      
Using Quantitative Systems Toxicology (QST) to Assess Drug Safety: The Experience of the DILIsim Initiative
SL
Walter Schubert  
Tissue Worlds2.0: MUS-ICR Robotics Deconding the Dark Space of Diseases-Experience with ALS to Therapy
3:30 - 3:50 pm 3:40 - 4:00 pm 3:30 - 3:50 pm
SL
Hidetoshi Arima   
Potential Use of Cyclodextrin Derivatives as Therapeutic Agents for Lysosomal Storage Disorders
 
SL
Laszlo Urban     
Title Awaited
SL
Sergey Suchkov 
Antibody-proteases as a Novel Biomarker and Thus the Unique Target to Manage Demyelination: A Green Light to be Opened for Biopharma
3:50 - 4:10  pm 4:00 - 4:20 pm 3:50 - 4:20 pm
SL
Jose Garcia Suarez   
Production of a Novel Recombinant Polypeptide fromSerratia marcescens for Cancer Therapy
SL
Peter Juhasz      
Title Awaited
IL
Achilleas Gravanis
Biomarker Potential of Several Mirnas for the Early Diagnosis of Hepatocellular Carcinoma Related with HBV and HCV Infections
4:10 - 4:30 pm 4:20 - 4:40 pm 4:20 - 4:40 pm
SL
Mostafa Mostafa Abo Elsoud   
Effect of Gamma Irradiation on Biogenic Production of Tellurium Nanoparticles
SL
Graham Demsey     
Title Awaited
SL
Evan B. Siegel
Advancing New Biotechnology Products into Clinical Trials and Marketing Applications
4:30 - 4:50 pm 4:40 - 5:00 pm 4:40 - 5:00 pm
SL
Shamshad Begum Quraishi
A New Approach for Diagnosis of Wilson’s Disease and Bangladesh Perpective
SL
Tarek M. Mahfouz     
Small Molecule Affinities for Sirt-1 Deacetylase Enzyme
 
SL
Azamat Tynybekov
Radiation Risks and Bio Safety in Kyrgyzstan
4:50 - 5:10 pm   5:00 - 5:20 pm
SL
Ying Wang 
Chemistry in the Fast Lane-Enabling Technologies for Drug Discovery
  SL
Leyanis Rodriguez Vera
Pharmacometic Approach to Support Dosing Strategy ofNimotuzumab in Patients with Breast Cancer
COFFEE BREAK: 5:10 - 5:40 PM
             


 

 
DAY 3: Wednesday, July 12, 2017
Chairman: 
Co-Chairman:
JOINT PLENARY SESSION
Location: Ball Room ‘B’ - Level 3
Time Speakers                                                                                      Titles
9:00 - 9:45 am PL
Sidney Altman
(Nobel Laureate)
Novel Drug Design     
9:45 - 10:30 am PL
Alexander D. MacKerell, Jr
Can CADD Drive Drug Design and Development?  Rapid Estimation of Relative Binding Affinities Based on Pre-Computed Ensembles
10:30 - 11:15 am PL
Ferid Murad
(Nobel Laureate)
 
Application of Nitric Oxide Research to Drug Development
 
POSTER SESSION & LUNCH  BREAK: 11:15 - 1:15 PM
Locations Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
Lecture Hall 203
Level 2
Tracks Hot Topics in Medicinal Chemistry CNS Drug Discovery & Therapy Industrial & Manufacturing
    Medical Biotechnology
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
1:15 - 1:45 pm 1:15 - 1:50 pm 1:15 - 1:35 pm
IL
Pierfausto Seneci   
Function-oriented Synthesis (FOS), Rational Design and Serendipity: The AZA-tanshinone Story
KNL
D.K. Lahiri
Role of Non-coding RNAs in Alzheimer’s Disease
 
SL
Klaus Opwis
Textile-fixed (Bio-) Catalysts
1:45 - 2:05 pm 1:50 - 2:20 pm 1:35 - 1:55 pm
SL
Christine Gravier-Pelletier   
Bactrial Peptidoglycan, Still A Source of Inspiration Towards Antibiotics
IL
Cynthia A. Lemere
Immunotherapy for Alzheimer’s Disease: Where Do We Stand Now?
SL
Zayniddin Muhidinov
Fat and Waxes - Other Valuable Products from Plant Processing
2:05 - 2:25 pm 2:20 - 2:50 pm 1:55 - 2:15 pm
SL
Toshiaki Matsubara   
An Insight into the Mechanism of the Electron-Transfer Induced Repair of the (6-4)T-T Photoproduct of DNA bvthe Photolvase.  A Computational Study
IL
Nigel H. Greig
Proinflammatory Cytokine Inhibitors for the Treatment of Neurodegenerative Disorders
SL
Mehmet Sami Seryn Serin
Biomarker Potential of Several Mirnas for the Early Diagnosis of Hepatocellular Carcinoma Related with HBV and HCV Infections
2:25 - 2:45 pm 2:50 - 3:20 pm 2:15 - 2:35 pm
SL
Daniele Passarella   
Self-assembling Drug-conjugates for anti-cancer Targeting and Treatment
IL
Jack T. Rogers
Cooperative RNA Modulation to Improve Iron Homeostasis Specific to Neurons while Providing Anti-amyloid Efficacy as a Potential Alzhimer’s Disease Therapy
SL
Abu Salim Mustafa
Genomic Characterization of Brucella Strains Isolated from Human Brucellosis Patients in Kuwait
2:45 - 3:05 pm 3:20 - 3:50 pm 2:35 - 2:55 pm
SL
Andrea Cavalli   
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-RAD51 Disruptors
IL
Kumar Sambamurti
A Complex Cascade of Production and Degradation Determines the Yield of Aβ Yield in vivo
 
SL
Thurai Moorthy
Molecular DX: Meeting Clinical Expectations
3:05 - 3:25 pm 3:50 - 4:10 pm 2:55 - 3:15 pm
SL
Aramini Andrea    
TRPM8 Blockers: Rational Design of Novel Potent and Selective Small Molecule Chemical Series for Neuropathic Pain Relief
SL
 Banjamin Wolozin
Stress Granules and Neurodegeneration: Novel Targets for Therapy in Amyotrophic Lateral Sclerosis and Alzheimer’s Disease
 
 
SL
A.Arasteh Nodeh
Title Awaited
 
3:25 - 3:45 pm 4:10 - 4:30 pm 3:15 - 3:35 pm
SL
Steven Harper   
Selective HDACI’s for Non-Oncological Applications
 
SL
 William Andrew Kofke
Functional Genomics in Human Brain Ischemia
 
IL
Ispita Roy
Title Awaited
 
3:45 - 4:05 pm 4:30 - 4:50 pm 3:35 - 3:55 pm
SL
Brijesh Rathi   
Discovery of Multistage Antimalarials: Synergistic Fusion of Privilege Bioactive Scaffolds Triggers Growth Inhibition of Malaria Parasite Plasmodium falciparum
SL
Horng-Jyh Harn
Targeting Therapy of Malignant Brain Tumor by a Local Interstitial Delivery System Loading with a Novel Small Molecule.  IND for Phase 1/IIa Approved by FDA (IND 128388
SL
George Perry
Title Awaited
 
4:05 - 4:25 pm 4:50 - 5:10 pm 3:55 - 4:15 pm
SL
Maurizio Botta   
The First Molecule Interacting with a Host Protein for the Inhibition of Multiple Viruses
SL
Nicolas Marie
The mGlu7 Receptor: A New Target in the Therapy of Opiates Addiction?
SL
D.V. Singh
Title Awaited
COFFEE BREAK: 4:30 - 5:30 PM
           
           


 
 
DAY 4: Thursday, July 13, 2017
Chairman: 
Co-Chairman:  
JOINT PLENARY SESSION
 Location: Ball Room ‘B’ - Level 3
Time Speakers                                                                                   Titles
9:00 - 9:45 am PL
Vladimir Torchillin
Stimuli-Sensitive Multifunctional Combination Nanopreparations of siRNA and Chemotherapeutic Drugs to Treat Multidrug Resistant Cancer      
9:45 - 10:30 am PL
Steven A. Carr
Quantitative Proteomics in Biology, Chemistry and Medicine
10:30 - 11:15 am PL
Stuart L. Schreiber
Chemistry Towards Novel Mechanism-of-Action Compounds in Therapeutics Discovery
POSTER SESSION & LUNCH  BREAK: 11:15 – 1:15 PM
Locations Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
 
Tracks Structural Biology Cancer Targeted Drug Delivery / Cancer Biomarkers CNS Drug Discovery & Therapy
Hot Topics in Natural Products Biologics Drug Delivery & Targeting
Chairman:
Co-Chairman:
Chairman:
Co-Chairman:
 
1:15 - 1:50 pm 1:15 - 1:50 pm 1:15 - 1:35 pm
KNL
S. Samar Hasnain
Structure Based Approach in Drug Discovery and Identification of Ligand Binding Sites
 
SL
KNL
Rakesh Kumar
ERBB2 Transcriptome: From Biology to Genomics to Biology
SL
Dani Dermawan
Title Awaited
1:50 - 2:10 pm 1:50 - 2:10 pm 1:35 - 1:55 pm
SL
Nevim Aygun
Non-B DNA Structures as Candidate Drug Targets Against Structural Chromosomal Instability
SL
Daniela Dinulescu 
Predictive and Prognostic Biomarkers for Chemoresistancein Ovarian Cancer
SL
Ramesh Chandra
Title Awaited
2:10 - 2:30 pm 2:10 - 2:30 pm 1:55 - 2:15 pm
SL
B. Padmanabhan
Structure-based Drug Discovery of Small Molecule Modulators for Human Superoxide Dismutase I (hSOD1) Associated with ALS
SL
Ali Jahanian-Najafabadi
Title Awaited
 
SL
Jaspreet Kaur Randhawa
Title Awaited
2:30- 2:50 pm 2:30 - 2:50 pm 2:15 - 2:35 pm
SL
Geng-Long Hsu
Discovery of a Natural Product for the Treatment of Erectile Dysfunction
SL
Muhammad Younus
Lead residues in Lohi Sheep: A Hemato-biochemical and Histopathological Study
SL
Peter I. Ejidike
Title Awaited
 
2:50- 3:10 pm 2:50- 3:10 pm 2:35- 2:55 pm
SL
Geng-Long Hsu  
A Compound Inhibits Jointly Phosphodiesterase 1 and 5
SL
Vacant Slot
SL
Vacant Slot
    2:55- 3:10 pm
    SL
Vacant Slot

Event Categories
Keywords: access , audience, Clinical , conference , industry , network , networking , opportunities , opportunities, pharmaceutical




Comments








Events Calendar

SunMonTueWedThuFriSat
25 26 27 28 29 30 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 1 2 3 4 5

Tag Cloud

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99